CO2023014571A2 - Recubrimiento protector para composiciones farmacéuticas sensibles a la humedad - Google Patents

Recubrimiento protector para composiciones farmacéuticas sensibles a la humedad

Info

Publication number
CO2023014571A2
CO2023014571A2 CONC2023/0014571A CO2023014571A CO2023014571A2 CO 2023014571 A2 CO2023014571 A2 CO 2023014571A2 CO 2023014571 A CO2023014571 A CO 2023014571A CO 2023014571 A2 CO2023014571 A2 CO 2023014571A2
Authority
CO
Colombia
Prior art keywords
pharmaceutical compositions
protective coating
moisture sensitive
sensitive pharmaceutical
wax
Prior art date
Application number
CONC2023/0014571A
Other languages
English (en)
Inventor
Todd Anthony Stutzman
Allissa Robin Kerner
Joseph Michael Schnitz
Daniela Cioloboc
Original Assignee
Scherer Technologies Llc R P
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scherer Technologies Llc R P filed Critical Scherer Technologies Llc R P
Publication of CO2023014571A2 publication Critical patent/CO2023014571A2/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/282Organic compounds, e.g. fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/28Compounds containing heavy metals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/284Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/284Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846Poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/288Compounds of unknown constitution, e.g. material from plants or animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Botany (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Application Of Or Painting With Fluid Materials (AREA)
  • Paints Or Removers (AREA)

Abstract

Se proporcionan composiciones farmacéuticas y métodos para preparar composiciones farmacéuticas que comprenden tabletas recubiertas con cera. Específicamente, se puede aplicar un recubrimiento de cera a una tableta farmacéutica antes del proceso de recubrimiento de película.
CONC2023/0014571A 2021-06-07 2023-10-26 Recubrimiento protector para composiciones farmacéuticas sensibles a la humedad CO2023014571A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202163197880P 2021-06-07 2021-06-07
PCT/US2022/072742 WO2022261610A1 (en) 2021-06-07 2022-06-03 Protective coating for moisture sensitive pharmaceutical compositions

Publications (1)

Publication Number Publication Date
CO2023014571A2 true CO2023014571A2 (es) 2023-11-10

Family

ID=82482845

Family Applications (1)

Application Number Title Priority Date Filing Date
CONC2023/0014571A CO2023014571A2 (es) 2021-06-07 2023-10-26 Recubrimiento protector para composiciones farmacéuticas sensibles a la humedad

Country Status (11)

Country Link
EP (1) EP4351526A1 (es)
JP (1) JP2024520160A (es)
KR (1) KR20240019293A (es)
CN (1) CN117440800A (es)
AU (1) AU2022289906A1 (es)
BR (1) BR112023022209A2 (es)
CA (1) CA3219239A1 (es)
CO (1) CO2023014571A2 (es)
IL (1) IL308749A (es)
MX (1) MX2023012915A (es)
WO (1) WO2022261610A1 (es)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ501248A (en) * 1997-08-26 2001-06-29 Aventis Pharma Inc Pharmaceutical composition for combination of piperidinoalkanol-decongestant
US20080096979A1 (en) * 2004-11-08 2008-04-24 Rubicon Research Pvt. Ltd. Aqueous Pharmaceutical Coating
CN104470371A (zh) * 2012-07-18 2015-03-25 丹尼斯科美国公司 熔化延迟的颗粒
JP2023502389A (ja) * 2019-11-21 2023-01-24 アレクシオン ファーマシューティカルズ, インコーポレイテッド ウィルソン病患者における神経損傷を低下させるための方法

Also Published As

Publication number Publication date
BR112023022209A2 (pt) 2024-02-06
KR20240019293A (ko) 2024-02-14
CN117440800A (zh) 2024-01-23
CA3219239A1 (en) 2022-12-15
WO2022261610A1 (en) 2022-12-15
AU2022289906A1 (en) 2023-11-09
EP4351526A1 (en) 2024-04-17
JP2024520160A (ja) 2024-05-21
IL308749A (en) 2024-01-01
MX2023012915A (es) 2024-01-11

Similar Documents

Publication Publication Date Title
DOP2020000102A (es) Compuestos útiles para inhibir a cdk7
CO2019007839A2 (es) Composiciones y métodos para inhibir la acción de la arginasa
UY37732A (es) Complemento para piensos
PE20200478A1 (es) Nuevas formulaciones y composiciones de cannabis en comprimidos y metodos para su elaboracion
BR112017000730B8 (pt) Derivados de pirrolidinona como inibidores de metap-2, e medicamentos
EA201692043A1 (ru) Лекарственная форма иммунодепрессанта
BR112017013598A2 (pt) composições de revestimento de película entérico, método de revestimento, e formas revestidas
EP3741687A4 (en) INDIVIDUAL PACKAGING DEVICE FOR TABLETS
CL2016002678A1 (es) “compuestos derivados de heteroarilo, ligantes d1; composición farmacéutica que los comprende; útiles en el tratamiento de enfermedades del snc, autoinmune, metabólicas, entre otras”. pct
ES2930589R1 (es) Envase que contiene cápsulas hidrosolubles
CO2023014571A2 (es) Recubrimiento protector para composiciones farmacéuticas sensibles a la humedad
CO2019000604A2 (es) Composición vaginal que comprende una combinación de estrógeno y vitamina d
UY35750A (es) Moduladores octahidro-ciclopenta[c] pirrol negativos de nr2b
TWD191369S (zh) 產品包裝之部分
MX2017006561A (es) Formulaciones farmaceuticas de matriz comprenden dimetilfumarato.
AR110134A1 (es) Pastilla liberación no abrupta de una dosis inducida por alcohol basado en alcohol polivinílico
EP3874954A4 (en) SOLID COMPOSITION FOR PLANT CARE WITH FUNGI SCLEROTIUM AND ITS USE
UA113442C2 (xx) Ентеросорбент
EA201991288A1 (ru) Фармацевтические композиции на основе дабигатрана
TR201722102A2 (tr) Levodropropizin İçeren Farmasötik Bir Ürün
AR103253A1 (es) Composición de compuestos de salicilato
CR20150411A (es) Composiciones farmacéuticas que contienen dexketoprofeno y tramadol
AR100820A1 (es) Formulaciones de comprimido bi-capa de ciclofosfamida y capecitabina y administración metronómica altamente fraccionada de las mismas
UA120295U (uk) Лікарській засіб антитромбоцитарної дії
TR201714736A2 (tr) Kabuklu kuruyemi̇ş ambalajlari i̇çi̇n seperatör